Application | Comment | Organism |
---|---|---|
analysis | development of activity-based probes by reengineering of a ubiquitin-charged E2 conjugating enzyme using tosyl-substituted doubly activated genes and application in profiling the transthiolation activity of the RBR E3 ligase Parkin in vitro and in cellular extracts | Homo sapiens |
medicine | parkin patient disease-associated mutation largely mediate their effect by altering transthiolation activity | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
A46P | parkin disease mutant, loss of activity | Homo sapiens |
C431F | parkin disease mutant, loss of activity | Homo sapiens |
G430D | parkin disease mutant, loss of activity | Homo sapiens |
K161N | parkin disease mutant, loss of activity | Homo sapiens |
K211N | parkin disease mutant, loss of activity | Homo sapiens |
K27N | parkin disease mutant, 0.7fold reduction in activity | Homo sapiens |
R275W | parkin disease mutant, loss of activity | Homo sapiens |
R42P | parkin disease mutant, 2.2fold activation of activity | Homo sapiens |
S65A | parkin disease mutant, loss of activity | Homo sapiens |
T415N | parkin disease mutant, loss of activity | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O60260 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
neuron | endogenous Parkin is activated in neuronal cell lines in response to mitochondrial depolarization | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
[E2 ubiquitin-conjugating enzyme UBE2L3]-S-ubiquitinyl-L-cysteine + [Miro1]-L-lysine | - |
Homo sapiens | [E2 ubiquitin-conjugating enzyme UBE2L3]-L-cysteine + [Miro1]-N6-ubiquitinyl-L-lysine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Parkin | - |
Homo sapiens |